Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2018-08-27
2019-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
With this dramatic increase in caesarean section rates, it is urgent to identify factors that may affect perinatal morbidity. Indeed, such factors can be classified into:
* Modifiable factors: surgical technique, anesthesia technique, operator experience, operative time
* Not modifiable factors: characteristics inherent to the mother: BMI, gravidic pathology, number of caesareans...
Majority of previous studies focused on anesthetic factors. A global vision integrating all parameters is necessary in order to best guide the preventative measures to be put in place.
our Objectives were : To Identify and to Analyze Perinatal Morbidity Factors During Caesarean Section
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal Birth After Caesarean Section - Effect on Maternal Psychosocial Function
NCT00294411
Maternal Hypotension During Cesarean Section and Short Term Neonatal Outcome.
NCT00330512
Timing of Planned Caesarean Section and Morbidity of the Newborn
NCT00835003
Anesthetic and Obstetric Outcomes in Morbidly Obese Pregnancy and Cesarean Delivery
NCT03590951
Chronic Pain After Childbirth - Caesarean Section Compared to Vaginal Delivery and the Impact of Pre-existing Pain
NCT03216044
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Non-interventional descriptive longitudinal prospective study.
II- Location and period of study:
The study tooked place in the obstetrics and gynecology department of the Mongi Slim La Marsa University Hospital from 27 august 2018 until 10.04.2019.
III- The study population:
Was defined by all women with indication of an elective caesarean section in our department during the study period.
IV-The eligibility criteria:
1. The inclusion criteria:
* Monofetal pregnancy
* Age over 18 years old
* Term Pregnancy ≥ 37SA
* Elective caesarean section
2. The non-inclusion criteria:
* Fetal pathology known prenatally like intrauterine severe growth retardation with Doppler abnormalities, fetal malformation or a known fetal genetic defect.
* Anomaly of placental adhesion.
* Caesarean in a context of medical or obstetric emergency.
3. Exclusion criteria:
* Caesarean section performed under general anesthesia following failure of locoregional anesthesia.
* Refusal of the woman to participate in the study.
* Impossibility or failure to study the neonatal acid-base balance on the umbilical cord.
V-Investigators:
1. The resident responsible for the study :
He was responsible for the inclusion and collection of preoperative and postoperative data.
2. Surgeons :
They immediately after surgery reported on the patient information sheet the surgical features of the cesarean section: the technique used, the methods of fetal extraction, the difficulties encountered...
VI- The judgment criteria:
* The acid-base balance of the newborn that will be evaluated by the measurement of neonatal PH at the umbilical cord and the neonatal eucapnic \[1-2-3\].
* The APGAR score at 5 minutes \[4\]
* Rates of transfer to neonatal intensive care unit ( NICU) and reason for hospitalization.
VII-The progress of the study:
1. The pre-inclusion visit
All the patients followed at the outpatient clinic were informed of the study during the prenatal visit of the 8th month.
The resident responsible for the study checked the eligibility criteria and informed the patient of the research objectives, its progress and the expected benefits of the research.
He answered all questions about Cesarean the study. A period of reflection until the day of delivery was left for signing the consent form. (see annexes 1 and 2)
2. The inclusion visit The resident in charge of the study was responsible for the final verification of the eligibility criteria and obtaining the written informed consent of the patient in Arabic (Appendix 1) and in French (Appendix 2).
If the patient agreed to participate, the investigator wrote his name and surname in clear, date and sign the consent form.
The patients recruited were chronologically assigned a number until the end of the study.
3. The day of cesarean section Once the patient had been selected for the study, her delivery was planned according to gestational age and respected the usual recommendations and protocols of use in the department.
Thus, the indication of cesarean delivery and the date of the operation were not affected by the inclusion of the patient in this observational study.
Investigators described the anesthetic and surgical techniques. Thus, the patient file was completed prospectively and specified the items relating to
* The surgeon:
The rank of the operator and his experience in caesarean surgery.
-Caesarean technique: Indeed, two caesarean techniques are used in our department and the choice between the two was attributed to the operator.
* The intraperitoneal Misgav Ladach technique \[5\]
* Extraperitoneal caesarean section according to the technique "French ambulatory cesarean section" (FAUCS) \[6\]
* The different operating times:
* Time between the beginning of the anesthesia and the incision of the skin.
* Time between skin incision and fetal extraction.
* Time between hysterotomy and fetal extraction or actual duration of fetal extraction.
* The modalities of fetal extraction:
* fetal presentation
* Possible use of instruments
* Use of maneuvers for intraoperative fetal extraction
* Operator's subjective evaluation of the degree of difficulty encountered to achieve fetal extraction
* Neonatal outcome:
* The neonatal PH measured at the umbilical cord.
* The eucapnic neonatal PH.
* The Apgar score at 5 minutes.
* Possible hospitalization in neonatology department and in which case its reason.
VIII-Statistic study:
We performed a correlation Pearson study between the different operating times measured during the study and the value of the neonatal eucapnic PH.
We performed a logistic regression to identify among the used variables the factors that significantly and independently influenced the neonatal outcome. We identified two major events : neonatal ph\<7.15 and neonatal ph \<7.1
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
neonates with acute acidosis
neonates with Cord blood gases measured immediately after birth inferior to 7.15
elective caesarean section
elective caesarean section
neonates with a normal ph
neonates with Cord blood gases measured immediately after birth of at least 7.15
elective caesarean section
elective caesarean section
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
elective caesarean section
elective caesarean section
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age over 18 years old
* Term Pregnancy ≥ 37SA
* Indication for Elective caesarean section
Exclusion Criteria
* Anomaly of placental adhesion.
* Caesarean in a context of medical or obstetric emergency.
* Caesarean section performed under general anesthesia following failure of locoregional anesthesia.
* Refusal of the woman to participate in the study.
* Impossibility or failure to study the neonatal acid-base balance on the umbilical cord.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Tunis El Manar
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kaouther Dimassi
associate professor in obstetrics and gynecoloy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
kaouther simassi, MD
Role: PRINCIPAL_INVESTIGATOR
university tunis el manar , faculty of medicine Tunis, TUNISIA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaouther Dimassi
Tunis, Sidi Daoued La Marsa, Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
perinatal morbidity mongi slim
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.